This month’s journal-based CME article is titled "Impact Of Direct-Acting Antivirals (DAAs) And Sustained Virologic Response (SVR) On Overall Survival In Patients With Chronic Hepatitis C Virus-Associated Hepatocellular Carcinoma And Interventional Oncology".
This is a retrospective analysis of patients diagnosed with hepatocellular carcinoma (HCC) who underwent interventional oncology (IO) procedures. The authors focused on those with hepatitis C (HCV) cirrhosis who also underwent therapy with DAAs.
To receive CME credit for this journal-based CME activity, participants must read the journal article and score 75% or better on the post test. Participants will have three opportunities to score 75% or better.
After participating in this journal-based CME activity, learners should be able to:
- Explain the impact of DAAs in patients receiving IO procedures
- Described overall survival in patients undergoing locoregional therapy for HCC
JVIR CME Editor
Daniel Sheeran, MD
University of Virginia, Charlottesville, VA
William M. Kamp, B.S 1
Cortlandt M. Sellers, M.D.1
Stacey Stein, M.D.2
Joseph K. Lim, M.D.3
Hyun S. Kim, M.D.1,2,4
1. Section of Interventional Radiology, Department of Radiology and Biomedical Imaging, Yale School of Medicine, 330 Cedar Street, New Haven, CT 06510, USA
2. Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, 330 Cedar Street, New Haven, CT 06510, USA
3. Section of Digestive Diseases and Yale Liver Center, Yale School of Medicine, 330 Cedar Street, New Haven, CT 06510, USA
4. Yale Cancer Center, Yale School of Medicine, New Haven, CT 06510, USA